Ambac Financial Group (OSG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
A special meeting is called to approve the sale of all shares of Ambac Assurance Corporation (AAC) to American Acorn Corporation, owned by Oaktree Capital Management, for $420 million in cash, subject to adjustments.
The board unanimously recommends approval of the sale, an advisory vote on executive compensation related to the sale, and the right to adjourn the meeting if more votes are needed.
The sale is considered a disposition of substantially all assets under Delaware law and requires majority shareholder approval.
Proceeds will be used to repay acquisition funding, cover transaction costs, initiate a $50 million share repurchase program, and for general corporate purposes, including further acquisitions.
Following the sale, the company will focus on specialty property and casualty insurance and insurance distribution businesses.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the sale of AAC, (2) advisory approval of executive compensation in connection with the sale, and (3) the right to adjourn the meeting to solicit more votes if needed.
Approval of the sale requires a majority of outstanding shares; the compensation and adjournment proposals require a majority of votes cast.
No appraisal or dissenters' rights are available to shareholders.
Board of directors and corporate governance
The board unanimously supports all proposals and recommends a "FOR" vote.
After the sale, the board and most senior executives will remain, except for two executives transferring to the buyer.
The buyer will have the right to designate one director to the board upon exercising more than 50% of the warrant and holding at least 4% of common stock.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025